Advertisement
Management of high-risk RMSK in the pre-and current eras of neoadjuvant therapy
Analysis is one of the largest-ever series of RMSK outcomes, first to include all RMSK patients
Model identifies target OS at which economic benefits of treatment outpace placebo
Side effects and management strategies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement